We report our experience with 42 patients who developed persistent tardive dystonia during or immediately after (within 2 months) treatment with antipsychotic drugs. We call this condition "tardive dystonia" to distinguish it from choreic tardive dyskinesia, which differs clinically. (A similar term was used by Keegan and Rajput-" for a single patient. The term "tardive dystonia" has been used also to describe the appearance of dystonia months or years after static cerebral injury." We prefer the term delayed-onsetdystonia for these cases.s") We do not, by this terminology. wish to advocate that tardive dystonia is a separate entity from oral choreictardi ve dyskinesia, Both are types of tardive dyskinesia, as they are persistent movement disorders that follow chronic antipsychotic use, We define dystonic movements as sustained, involuntary twisting movements, generally slow, which may affect the limbs, trunk, neck, or face. 24 That antipsychotic drugs can cause persistent dyskinesias has been recognized since the 19505.1.2 The term "tardive dyskinesia" has been applied,'! because the movements usually occur as a late complication of antipsychotic drug therapy, unlike acute dystonia or parkinsonism, which typically occur earlier. The first reports of the condition described choreic movements affecting predominantly the oral region: tongue protrusion, lip smacking and puckering, and chew;ng.~-8 These movements are now recognized as the predominant and characteristic feature. The oral movements are often accompanied by chorea of the hands and feet.';-'l There may also be myoclonus'? or dystonia,9-12 including hyperextension and abduction of the anus, exaggerated lordosis, and pelvic rotation.
There have been a few reports of dystonia as thE;predominant late and persistent movement disorder caused by antipsychotic drugs. Opisthot .
-----------------------------------
Article abst~act-It is not widely recognized that antipsychotic drugs can cause late-onset and persistent dystonia.
This dystonia, which we call tardive dystonia. is to be distinguished from acute dystonic reactions, which are transiem, and from classic tardive dyskinesia, which is a choreic disorder that predominantly affects the oral .. region. We present 42 patients with tardive dystonia. The age of onset of dystonia was 13 to 60 years. Symptoms began after 3 days to 11 years of antipsychotic therapy. Younge!' patients t-ended to have more generalized dystonia.
In a few patients. spontaneous remission occurred. but dystonia persisted rOT years in most. Therapy was rarely a complete success. The most frequently helpful medications were tetrabenazine \68% of patients improved) and anticholinergics ',390/<. improved), r There were 26 men and 16women in our series, a ratio of 1.6:1. The mean age of dystonia onset for men was 29.0 years, significantly less than the mean age of 41.5 years for women tp < 0.005), but there were no definite sex differences for severity of dystonia. Although five of the six patients with generalized dystonia were men, this number was too small to draw conclusions. Sixteen men and 11 women had segmental dystonia (1,45:1) , and 5 men and 4 women had focal dystonia (1.25:11. . All classes of antipsychotic drugs were iri1pli~' cated. Aliphatic, piperazine and piperidine phenothiazines, butyrophenones, molindone, and thioxanthines (often in combination) were responsible. Promethazine. a phenothiazine used clinically as an antiemetic, was the offending drug in one case.
It usually was impossible to determine exactly when dystonia started during a particular course of antipsychotic drug treatment, nor could we determine total cumulative doses of drugs prescribed, because either the complete institutional records were unavailable or the patient had unknown access to antipsychotics as an outpatient. Howev.e~, for each patient we could document when antIpsychotic drugs were first prescribed. The inter:val between that time and the onset of dystonia was recorded (tables 1 and 2).
The average duration ofexposure to antipsychotiC drugs was 3.7 years. In the younger patients (tab1e 1), the average duration of exposure was 2.8 yearS muscles with retrocolhs and slight torticollis to the left. There was mild dysarthria and involuntary right shOUl_ der shrugging. When he walked, there was dystonic posturing of' the hands. more on the right. At rest, there was involuntary sustained extension of the left foot. There was a 8-to Ifl-Hz postural of the hands, armE and shoulders. There. were no Kayser-Fleischer ringS on slit-lamp examination. Copper studies, serum ceruloplasmin, CSF. and CT were normal. Trihexyphenidyl 10 mg daily improved the painful neck pulling, but he continued to have right shoulder spasms 3 years after the onset of the dystonia.
Focal dystonia refers to dystonia that remains confined to its site of onset; segmental dystonia involves more than one body region; generalized dystonia involves an four limbs and axial structures.>' In all cases, other causes ofsecondary dystonia were excluded by clinical course and laboratory studies. By using the temporal relationship between antipsychotic treatment and appearance of dystonia as the criterion for the diagnosis of tardive dystonia, we may have included some cases that represent the chance occurrence of idiopathic dystonia developing during antipsychotic drug treatment. However, the likelihood of this coincidence is small.
We present two cases oftardive dystonia in detail to illustrate the clinical spectrum. Data from these and the remaining 40 cases as well as 15 cases from the literature are presented in tabular form.
Case reports. Patient 1. This man developedpersistent dystonia at age 19 years. The parents were non-Jewish. and there was no family history of dystonia. Birth was abnormal in being 2 weeks premature with a breech presentation. Developmental milestones were delayed; he did not walk until age 2 years. He was diagnosed to be mentally retarded at age 6 years. At age 17, he was placed in an institution because of aggressive behavior. During this time, he was treated with haloperidol 15 mg daily and chlorpromazine 450 mg daily, but it is not known for how long. He was again admitted at age 19 and treated with unknown doses of haloperidol, chlorpromazine, and thioridazine when he developed facial grimacing and abnormal trunk postures that persisted, On our examination, at age 21 years, he was mentally ·retarded. There were no Kayser-Fleischer rings on slitlamp examination. There was intermittent, sustained facial grimacing affecting predominantly the lower face, retrocollis, and opisthotonic trunk extension that was exacerbated by walk.:ing, and intermittent, sustained extension movements of the arms. The opisthotonus tended to force him off a chair, and he could not sit. There was no oral chorea. Withdrawal of anti psychotics did not diminish the movement disorder. Treatment with carbamazepine and valproate in succession was without benefit. Tetrabenazine caused sustained, forced jaw opening and oculogyric crisis, and so it was discon-, tinued. Ethopropazine 25 mg four times daily improved the dystonic movements. At most recent examination, age 22 years, he remained much improved on ethopropazine 150 mg each day.
Patient 19. At age 40 years, this man developed anxiety and was treated with fluphenazine 25 mg intramuscularly every month for 12 months. Two months after the cessation of the therapy he noted posterior neck stiffness, and in t.he next 6 months he noted involuntary pulling of the head backward, making it impossible for him to drive. In the next year, there was involuntary pulling of the head to the left with painful spasms on the right side ofthe neck and right shoulder. He developed tremor of both hands. As a result of the constant neck muscle spasms, his neck size increased from 15 1/2 to 18 inches in 1 year. Loxapine provided some relief of the spasms. Haloperidol and chlorpromazine did not affect the neck dystonia. Examination was unremarkable except for marked hypertrophy of the sternocleidomastoid to that seen in idiopathic torsion dystonia or secondary dystonia. For example, patients with focal tardive dystonia (torticollis, blepharospasm, or oromandibular dystonia"! were identical in appearance to patients with idiopathic focal dystonia. The pattern of dystonia distribution in our younger patients was distinctive, affecting face or neck in 16 of 18; none had dystonia of the leg or trunk without face or neck involvement (fig). Face, neck, arms, or trunk often were involved when the legs were normal. Six patients (14%) had generalized dystonia; most (27 of 42; 64%) had segmental dystonia; the remainder (9 of 42; 21%) had focal dystonia, usually restricted to face or neck. Only patient 17 became bedridden because of tardive dystonia. In 16 patients, there were other movement disorders in addition to dystonia. Eight had an oral chorea with masticatory movements typical of tardive dyskinesia; three young patients had myoclonus, and one of these patients had oral chorea as well; two patients had chorea of the hands; four older patients had tremor.
Patients were followedfrom 9 months to 11 years after the onset of dystonia, with a mean of 3.1 years. Antipsychotic medication (excluding tetrabenazine) was stopped in 29 patients, and these patients have been followed from 1 month to 6 years since discontinuation of antipsychotic drugs, with a mean of 1.5 years. Dystonia persisted in 37 ofthe 42 patients, including 24 ofthe 29 patients who stopped taking antipsychotic medication. The longest time that tardive dystonia peraistedafter discontinuation ofantipsychotic drugs was 6 years (patient 30) .
In several patients, there was a transient remission ofsymptoms when the dose ofantipsychotic drug was increased. We have not, however, considered such cases as remissions, because none of them had prolonged relief of symptoms. Five patients had true remissions of dystonia (patients 4, 15, 26, 34, and 36). They had been treated with antipsychotic drugs for 3 days, 1.25years, 4 months, 1.5 years, and 1.5 years, respectively, before the onset of dystonia. The interval from onset of dystonia to remission was determined bv our defin.ition of remission, which included cessation of all drug therapy. Remission was achieved at 1, 4, 1.5,1.5, and 4 years, respectively, after the onset of dystonia.
There were no consistent abnormalities 'in diagnostic studies. Ten patients had exammation of CSF; one showed a slightly increased protein i85 mg per deciliter). Seventeen patients had CT scans . . / Usually, a single body region was affected with :'nYstoniaat the onset but occasionally, multiple . pltes were involved; consequently, the number of -, :hodyregions initially involved in the following . !data exceeds the number of patients. For all 42 /~atients, the face or neck was the first region af-;Jectedin 29 of 43 instances; among the younger ·.'~atients, face or neck was first affected in 11 of .·20 instances. ;: Theclinical appearance of dystonia was identical f .'j l -s . . j. - Table 4_ ··;T· .:t Discussion. Our criteria for the diagnosis oftardive dystonia were: (1) the presence of chronic dystonia, (2) a history of antipsychotic drug treatment preceding or concurrent with the onset of dystonia, (3) exclusion ofknown causes of secondary dystonia by appropriate clinical and laboratory evaluation, and (4) a negative family history fOT dystonia. The clinical course and diagnostic studies did not support a diagnosis of any of the known causes of secondary dystonia, including Huntington disease, Parkinson disease, Hallervordern-Spatz disease,' cerebral lipidosis, or mass lesions." Wilson disease tipsychotic drugs commonly suppressed dystonia, and we occasionally used haloperidol, for example, in the acute management of particularly severe cases. However, they did not help in every case. Most of our experience has been with tetrabenazine and anticholinergics. Of 19 patients treated with tetrabenazine, 13 (68%) showed some benefit. Of 18 patients treated with anticholinergic drugs Ctrihexyphenidyl, benztropine, proeyclidine, and ethopropazine),7 (39%) were helped. Occasionally these drugs had considerable benefit. Patient 1 showed marked improvement with ethoproprazine; patient 2 showed substantial, prolonged benefit from tetrabenazine. Twenty-seven patients were treated with drugs intended to diminish central dopaminergic transmission, either by dopamine depletion (tetrabenazine) or dopamine receptor blockade (e.g., phenothiazines). Improvement oc-.._..---curred·in 12 (44%)'patients,worsening in six (22%):
r----------------------------------------------------------------------------------------------------{
In nine patients (33%), there were mixed results with these agents, some causing improvement and others worsening dystonia. Thirteen patients were treated with drugs intended to enhance central cholinergic transmission (deanol, lecithin, and choline), and two (l5%) showed some benefit. older patients were women, and dystonia was usually restricted to the face or neck; tardive dyskinesia is also more common in older women.'·13.30.:J2.33 However, female preponderance among tardive dyskinesia patients has been questioned," and OUT findings may also be due to bias in a series of referred patients, undoubtedly selected for severity and persistence of dystonia. Female sex may be a risk factor for tardive dyskinesia only in older and more severe cases.:l:'·-37 It is premature to suspect that endocrine factors associated with female aging are relevant to the pathogenesis oftardive dystonia. Like oral choreic tardive dyskinesia, tardive' dystonia is caused by chronic treatment with any of the antipsychotic drugs, and it occurs in patients with various psychiatric and nonpsychiatric illnesses. Although these two types of tardive dyskinesia are clinically distinct, they may occur in combination in the same patient. They both can .be persistent. It is possible-that children 'are more likely to get tardive dystonia than oral choreic tardive dyskinesia, because the latter is rare in children.s" However, our patients are a referred group, and we cannot draw conclusions about the relative prevalence of these two forms of tardive dyskinesia in any age group.
Our retrospective review of therapeutic trials among these patients fails to provide a clear picture of the clinical pharmacology of tardive dystonia. Oral choreic tardive dyskinesia is usually suppressed by dopamine depleting or blocking agepts;~V but tardive dystonia was improved by these agents in only 44% of patients. On the other hand, anticholinergic drugs often exacerbate tardive dyskinesia;" but 39% of our patients with tardive dystonia improved with anticholinergic drugs, some remarkably. Without an understanding of the pharmacology of tardive dystonia, treatment is difficult and often unsuccessful. Because therapy often.is unsuccessful, and because tardive dystonia can be incapacitating and sometimes persistent, attention must be focusedon preventive measures. Tragically, many of these patients were treated with anti psychotics inappropriately for disorders such as anxiety or aggressive behavior. Even if antipsychotics are indicated and a patient develops tardive dystonia, the indications for treatrnentmust be reviewed, especially in younger patients. We believe that early recognition of the syndrome and withdrawal of antipsychotics may permit remission of the condition. In three of our patients, dystonia remitted when antipsychotics were stopped, but the disorder became permanent when antipsychotics were resumed. In addition, the five patients in our series who had remissions of dystonia were exposed to antipsychotic drugs, on the average, for briefer periods than other patients.
If antipsychotic drugs can be stopped, they should be. If the psychiatric illness, untreated, is incapacitating, antipsychotic therapy may need to be ·rt herefore, we cannot conclude that birth injury is j:' a predisposing factor for the development oftardi ve ,~. dystonia. It may be simply an associated factor. L.!f~wever,other a.uthorslS have suggested that birth 'rnjury may predispose to the development of dys-:i tenia, and our findings are at least compatible },. with that belief Birth injury also has been im-.;.plicated as a predisposing factor for dystonia in-.;.ducedby phenytoin " and carbamazepirie.P Birth tinjury may also influence the expression of in- 
